Mac Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.21 M
as on 10-12-2024
- Revenue 8.47%
(FY 2022)
- Profit -16.25%
(FY 2022)
- Ebitda 21.48%
(FY 2022)
- Net Worth 39.07%
(FY 2022)
- Total Assets 9.45%
(FY 2022)
About Mac Bio Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.21 M.
Tirlochan Dass and Monika Sharma serve as directors at the Company.
- CIN/LLPIN
U85100HR2012PTC047727
- Company No.
047727
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mac Bio Sciences Private Limited offer?
Mac Bio Sciences Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Pharmaceutical Syrup, Hand Sanitizers & Personal Hygiene, Face Wash, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Medicine.
Who are the key members and board of directors at Mac Bio Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tirlochan Dass  | Director | 21-Nov-2012 | Current |
| Monika Sharma | Director | 20-Aug-2018 | Current |
Financial Performance of Mac Bio Sciences.
Mac Bio Sciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.47% increase. The company also saw a substantial fall in profitability, with a 16.25% decrease in profit. The company's net worth Soared by an impressive increase of 39.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mac Bio Sciences?
In 2021, Mac Bio Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Apr 2013 | ₹5.21 M | Open |
State Bank Of Patiala Creation Date: 10 Apr 2013 | ₹1.00 M | Open |
How Many Employees Work at Mac Bio Sciences?
Mac Bio Sciences has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mac Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mac Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
